olfactory receptor family 5 subfamily M member 7 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR5M7P profile across patient tissues and cancer cell-line models. OR5M7P expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, OR5M7P is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, OR5M7P RNA expression shows 6,625 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight STAD, KIRC, and UCEC as cancer lineages where OR5M7P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR5M7P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR5M7P survival associations across molecular data types. OR5M7P RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR5M7P RNA expression–survival associations across cancer types. High OR5M7P expression shows unfavorable associations in STAD, KIRC, BLCA, LGG and KIRP, but favorable associations in ESCA. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for OR5M7P RNA expression.
This table summarizes OR5M7P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for OR5M7P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR5M7P shows lower tumor expression in KIRC. The KIRC box plot shows higher OR5M7P RNA expression in normal versus tumor tissue (log2 FC = −0.005, t-test p = .039).
This table shows molecular features associated with OR5M7P in patient tissues and cancer cell lines. In patient samples, OR5M7P shows the broadest associations at the RNA and protein expression levels, with UCEC recurring as the lineage with the largest associated feature set.
